Medicament for liver regeneration and for treatment of liver failure

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9186381
APP PUB NO 20140141510A1
SERIAL NO

14009738

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of a compound which inhibits the activity of MKK4 as a medicament for the treatment of a patient suffering from an impaired liver function, to the use of a compound as a medicament for the treatment of liver failure, including acute/fulminant or chronic liver failure and/or for increasing the regeneration of liver tissue in a patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELMHOLTZ ZENTRUM FUER INFEKTIONSFORSCHUNG GMBHBRAUNSCHWEIG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wuestefeld, Torsten Braunschweig, DE 6 42
Zender, Lars Braunschweig, DE 22 121

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00